GS
BSX icon

GTS Securities’s Boston Scientific BSX Stock Holding History

GTS Securities’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-6,962
Closed -$437K – 1397
2026
Q1 		$437K Sell
6,962
-6,968
-50% -$557K 0.02% 834
2025
Q4 		$1.33M Buy
13,930
+4,682
+51% +$459K 0.05% 331
2025
Q3 		$903K Buy
+9,248
New +$958K 0.03% 464
2025
Q2 		– Sell
-8,574
Closed -$865K – 1258
2025
Q1 		$865K Buy
8,574
+90
+1% +$9.06K 0.04% 449
2024
Q4 		$758K Sell
8,484
-73,354
-90% -$6.46M 0.04% 452
2024
Q3 		$6.86M Buy
81,838
+48,538
+146% +$3.83M 0.01% 700
2024
Q2 		$2.56M Sell
33,300
-2,816
-8% -$206K 0.01% 1309
2024
Q1 		$2.47M Sell
36,116
-211
-0.6% -$13.6K ﹤0.01% 1342
2023
Q4 		$2.1M Buy
36,327
+27,848
+328% +$1.49M ﹤0.01% 1619
2023
Q3 		$448K Buy
+8,479
New +$445K ﹤0.01% 2730

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

GTS Securities's BSX Position: Q2 2026 in Review

GTS Securities sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 6,962 shares — an estimated $437K sold.

GTS Securities first reported a position in BSX in Q3 2023 and held it in 10 quarters. The position peaked at $6.86M in Q3 2024. 1,482 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • GTS Securities reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • GTS Securities sold 6,962 Boston Scientific shares in Q2 2026, an estimated $437K.
  • GTS Securities first reported a position in Boston Scientific in Q3 2023 and held it in 10 quarters.
  • GTS Securities's Boston Scientific position peaked at $6.86M in Q3 2024.
  • 1,482 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on GTS Securities's 13F filing for Q2 2026, filed 14 Aug 2026.